Type 2 diabetes and the risk of Parkinson's disease

Diabetes Care

Volumn 30, Issue 4, 2007, Pages 842-847

  Hu, Gang ^a,b   Jousilahti, Pekka ^a,c   Bidel, Siamak ^a,b   Antikainen, Riitta ^d   Tuomilehto, Jaakko ^a,b,e  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; INCIDENCE; LEISURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; PHYSICAL ACTIVITY; REGISTER; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

ADULT; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS;

EID: 34147190028     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2011     Document Type: Article

References (40)

1. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053, 2004
2. Hu G, DECODE Study Group: Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46:608-617, 2003
3. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J: Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 48:856-861, 2005
4. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D: Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956-962, 2005
5. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E: Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population. Stroke 27:210 -215, 1996
6. Lawes CM, Parag V, Bennett DA, Suh I, Lam TH, Whitlock G, Barzi F, Woodward M: Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 27:2836-2842, 2004
7. Hu G, Sarti C, Jousilahti P, Peltonen M, Qiao Q, Antikainen R, Tuomilehto J: The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 36:2538-2543, 2005
8. Hu G, Jousilahti P, Sarti C, Antikainen R, Tuomilehto J: The effect of diabetes and stroke at baseline and during follow-up on stroke mortality. Diabetologia 49: 2309-2316, 2006
9. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ: Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145:301-308, 1997
10. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM: Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53:1937-1942, 1999
11. Peila R, Rodriguez BL, Launer LJ: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 51:1256-1262, 2002
12. Sandyk R: The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 69:125-130, 1993
13. Pressley JC, Louis ED, Tang MX, Cote L, Cohen PD, Glied S, Mayeux R: The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 60:87-93, 2003
14. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H: Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. Parkinsonism Relat Disord 12:185-189, 2006
15. Scigliano G, Musicco M, Soliveri P, Piccolo I, Ronchetti G, Girotti F: Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke 37:1184-1188, 2006
16. Craft S, Watson GS: Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3:169-178, 2004
17. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P: Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 29:49-56, 2000
18. Pajak A, Kuulasmaa K, Tuomilehto J, Ruokokoski E: Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years: TheWHOMONICA Project. World Health Stat Q 41:115-140, 1988
19. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
20. WHO Consultation: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999
21. Hu G, Jousilahti P, Nissinen A, Antikainen RL, Kivipelto M, Tuomilehto J: Body mass index and the risk of Parkinson disease. Neurology 67:1955-1959, 2006
22. Hu G, Qiao Q, Silventoinen K, Eriksson JG, Jousilahti P, Lindstrom J, Valle TT, Nissinen A, Tuomilehto J: Occupational, commuting, and leisure-time physical activity in relation to risk for type 2 diabetes in middle-aged Finnish men and women. Diabetologia 46:322-329, 2003
23. Hu G, Barengo NC, Tuomilehto J, Lakka TA, Nissinen A, Jousilahti P: Relationship of physical activity and body mass index to the risk of hypertension: a prospective study in Finland. Hypertension 43:25-30, 2004
24. Hu G, Eriksson J, Barengo NC, Lakka TA, Valle TT, Nissinen A, Jousilahti P, Tuomilehto J: Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. Circulation 110:666-673, 2004
25. Hu G, Lindstrom J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J: Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 164:892-896, 2004
26. Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P: Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J 25:2212-2219, 2004
27. Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J: Leisure time, occupational, and commuting physical activity and the risk of stroke. Stroke 36:1994-1999, 2005
28. Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J: Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 28:799-805, 2005
29. Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J: Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Int J Obes (Lond) 30:1742-1749, 2006
30. Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P: Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291:1213-1219, 2004
31. Arvanitakis Z, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA: Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology 63:996-1001, 2004
32. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A: 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145, 1996
33. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A: Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17:14-20, 1998
34. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ: A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52:276-284, 2002
35. Hernan MA, Chen H, Schwarzschild MA, Ascherio A: Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol 54:170-175, 2003
36. Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A: Physical activity and the risk of Parkinson disease. Neurology 64:664-669, 2005
37. Abbott RD, Ross GW, White LR, Nelson JS, Masaki KH, Tanner CM, Curb JD, Blanchette PL, Popper JS, Petrovitch H: Midlife adiposity and the future risk of Parkinson's disease. Neurology 59:1051-1057, 2002
38. Rampello L, Alvano A, Battaglia G, Raffaele R, Vecchio I, Malaguarnera M: Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism. J Neurol 252:1045-1049, 2005
39. Thanvi B, Lo N, Robinson T: Vascular parkinsonism: an important cause of parkinsonism in older people. Age Ageing 34:114-119, 2005
40. Rektor I, Rektorova I, Kubova D: Vascular parkinsonism: an update. J Neurol Sci: 185-191, 2006